Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 23;18(8):e0290406.
doi: 10.1371/journal.pone.0290406. eCollection 2023.

Test performance of lateral flow rapid antigen tests for COVID-19 in Welsh adult care home staff using routine surveillance data

Craig Hogg  1 , Sian Boots  1 , Daniel Howorth  1 , Christopher Williams  1 , Margaret Heginbothom  1 , Jane Salmon  1 , Robin Howe  2
Affiliations

Test performance of lateral flow rapid antigen tests for COVID-19 in Welsh adult care home staff using routine surveillance data

Craig Hogg et al. PLoS One. .

Abstract

Background: Lateral flow tests (LFTs) have been used to screen for SARS-CoV2 in Wales since January 2021. Between May and August 2021, adult care home staff policy was for biweekly Innova LFT and weekly Polymerase Chain Reaction (PCR) testing while asymptomatic. We estimated test performance of LFTs conducted in adult care home staff using PCR tests as a reference standard.

Methods: Test results from surveillance data were matched by individual where both LFT and PCR were taken on the same day. We calculated sensitivity, specificity, positive and negative predictive values, and agreement using Matthew's correlation coefficient. Ct values of positive PCR results were compared by matched LFT result. Analysis was conducted using R v4.1.3.

Results: We analysed 115,593 test pairs, 499 (0.43%) of which were PCR positive. Median age was 48 (IQR: 22) and 85.00% of the study population were female. Test result agreement was 99.59% (95%CI 99.55-99.63; MCC: 0.38, p<0.001). Sensitivity and specificity were 25.65% (95%CI 22.02-29.67) and 99.91% (95%CI 99.89-99.93), respectively. PPV was 55.90% (95%CI 49.42-62.17) and NPV was 99.68% (95%CI 99.64-99.71). Crude Ct values were significantly lower in positive PCR tests matched to a positive LFT compared to a negative LFT.

Conclusions: Specificity and negative predictive value were high in an asymptomatic population of care home staff indicating this test is an effective tool for identifying cases of SARS-CoV-2 infection during periods of high prevalence where transmission is likely, due to the presence of high viral loads. Positive predictive value results are lower than existing literature yet should be considered in light of the asymptomatic study population and low prevalence (under 1%) at the time most of these tests were conducted. Performance improved at times of higher prevalence during the study. These results suggest that whilst lateral flow tests are effective for identifying SARS-COV-2 infections with high viral loads, they are not effective at identifying cases with a low viral load. When an LFT provides a negative result, false negatives should be considered and additional diagnostic tests performed.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Prevalence estimate comparison (left axis) and Positive Predictive Value (right axis) by week.
Data excluded for weeks 17 and 35 due to incomplete weekly data.
Fig 2
Fig 2. Minimum target Ct value, by matched LFT result.
Labels show median of each group and statistical difference between groups.
See this image and copyright information in PMC

References

    1. WHO Director-General’s opening remarks at the media briefing on COVID-19. World Health Organisation. 2020. https://www.who.int/director-general/speeches/detail/who-director-genera...
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-ncov and naming it SARS-COV-2. Nature Microbiology. 2020;5(4):536–44. doi: 10.1038/s41564-020-0695-z - DOI - PMC - PubMed
    1. Drakesmith M, Collins B, Jones A, Nnoaham K, Thomas DR. Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-COV-2 infections with lateral flow devices: A modelling and Economic Analysis Study. BMC Health Services Research. 2022;22. doi: 10.1186/s12913-022-08511-3 - DOI - PMC - PubMed
    1. Du Z, Pandey A, Bai Y, Fitzpatrick MC, Chinazzi M, Pastore y Piontti A, et al.. Comparative cost-effectiveness of SARS-COV-2 testing strategies in the USA: A modelling study. The Lancet Public Health. 2021;6. doi: 10.1016/s2468-2667(21)00002-5 - DOI - PMC - PubMed
    1. Hsieh WY, Lin CH, Lin TC, Lin CH, Chang HF, Tsai CH, et al.. Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies. Diagnostics. 2021. Sep 24;11(10):1760. doi: 10.3390/diagnostics11101760 - DOI - PMC - PubMed